Fate TherapeuticsFATE
那斯達克 · USD
2.25
+0.15
(+7.14%)
收盤 05/23 03:59 (UTC+8)
05/23 03:59 (UTC+8)
Fate TherapeuticsFATE
2.25
+0.15
(+7.14%)
財務數據
損益表
- 0.02
- 0.02
- 0.07
- 0.03
- 0.02
- 0.02
- 0.02
- 0.02
- 0.01
- 0.01
- -13.79
- 14.86
- 251.79
- -54.61
- -39.49
- -12.42
- 17.07
- -8.70
- -21.37
- -5.11
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 1,299 | 1,369 | 1,741 | 1,907 | 1,629 | 1,860 | 3,074 | 6,772 | 1,925 | 1,676 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 1,299 | 1,369 | 1,741 | 1,907 | 1,629 | 1,860 | 3,074 | 6,772 | 1,925 | 1,676 |
營業費用 | 34,299 | 36,090 | 36,476 | 38,875 | - | - | - | - | - | 49,751 |
研發費用 | 24,703 | 25,425 | 25,838 | 27,430 | 29,136 | 33,609 | 34,650 | 34,604 | 32,138 | 31,816 |
推銷及管理費用 | 9,596 | 10,665 | 10,638 | 11,445 | 13,773 | 15,262 | 20,801 | 17,251 | 20,855 | 17,935 |
非經常性項目費用 | - | - | - | - | - | 14,737 | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -33,000 | -34,721 | -34,735 | -36,968 | -41,280 | -61,748 | -52,377 | -45,083 | -51,068 | -48,075 |
其他收入及費用 | 1,787 | 2,347 | 2,485 | 2,898 | 3,659 | 9,595 | 4,699 | 6,656 | 3,064 | 3,953 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -31,213 | -32,374 | -32,250 | -34,070 | -37,621 | -52,153 | -47,678 | -38,427 | -48,004 | -44,122 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -31,213 | -32,374 | -32,250 | -34,070 | -37,621 | -52,153 | -47,678 | -38,427 | -48,004 | -44,122 |
基本每股稅後盈餘(元) | -0.26 | -0.27 | -0.27 | -0.29 | -0.32 | -0.44 | -0.40 | -0.33 | -0.47 | - |
稀釋每股稅後盈餘(元) | -0.26 | -0.27 | -0.27 | -0.29 | -0.32 | -0.45 | -0.40 | -0.32 | -0.47 | -0.45 |
基本平均股數(千股) | 120030.00 | 119245.00 | 118998.00 | 118528.00 | 118375.00 | 117794.00 | 117769.00 | 117468.00 | 101104.00 | - |
稀釋平均股數(千股) | 120030.00 | 119245.00 | 118998.00 | 118528.00 | 118375.00 | 117794.00 | 117769.00 | 117468.00 | 101104.00 | - |
還原基本每股稅後盈餘(元) | -0.26 | -0.27 | -0.27 | -0.29 | -0.32 | -0.44 | -0.40 | -0.33 | -0.47 | - |
還原稀釋每股稅後盈餘(元) | -0.26 | -0.27 | -0.27 | -0.29 | -0.32 | -0.45 | -0.40 | -0.32 | -0.47 | -0.45 |
還原基本平均股數(千股) | 120,030 | 119,245 | 118,998 | 118,528 | 118,375 | 117,794 | 117,769 | 117,468 | 101,104 | - |
還原稀釋平均股數(千股) | 120,030 | 119,245 | 118,998 | 118,528 | 118,375 | 117,794 | 117,769 | 117,468 | 101,104 | - |
EBITDA(千元) | -29,067 | -30,192 | -29,833 | -31,639 | -35,356 | -48,870 | -45,267 | -36,429 | -45,814 | -42,143 |